🔗 Share this article

Chancellor Rachel Reeves has stated she is planning "focused measures to address cost of living pressures" in the upcoming Budget.

During an interview with the BBC, she stated that lowering price rises is a shared duty of both the administration and the central bank.

The United Kingdom's inflation rate is forecast to be the highest among the G7 industrialized countries this year and the following year.

Possible Utility Bill Interventions

Reports indicate the administration could intervene to bring down energy bills, for instance by cutting the current 5% rate of VAT applied on energy supplies.

Another approach is to reduce some of the government charges currently added to household expenses.

Fiscal Limitations and Analyst Predictions

The administration will obtain the latest draft from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will reveal how much room there is for these measures.

The view from the majority of economists is that Reeves will have to declare tax increases or budget cuts in order to adhere to her self-imposed borrowing rules.

Earlier on the same day, estimates showed there was a twenty-two billion pound gap for the Treasury chief to address, which is at the lower end of projections.

"It is a joint task between the central bank and the government to continue tackling some of the causes of inflation," Reeves told reporters in the US capital, at the conferences of the IMF and global financial institution.

Tax Pledges and International Concerns

While much of the attention has been on probable tax increases, the chancellor said the most recent data from the fiscal watchdog had not altered her commitment to campaign commitments not to increase tax levels on income tax, VAT or National Insurance.

She blamed an "uncertain global environment" with increasing geopolitical and trade tensions for the Budget revenue measures, probably to be focused on those "most able to pay."

International Trade Tensions

Addressing concerns about the United Kingdom's commercial links with China she said: "The UK's national security always are paramount."

Recent announcement by China to increase export controls on critical minerals and other resources that are crucial for advanced tech production led US President Donald Trump to propose an additional 100% tariff on goods from the Asian country, increasing the possibility of an all-out commercial conflict between the two economic giants.

The US Treasury Secretary labeled the Chinese action "commercial pressure" and "a international production control attempt."

Questioned on accepting the American proposal to join its dispute with the Asian nation, the Chancellor said she was "very concerned" by Chinese measures and called on the Chinese government "not to put up barriers and limit trade."

She said the move was "bad for the international commerce and causes additional challenges."

"It is my opinion there are areas where we must challenge China, but there are also important opportunities to trade with Chinese markets, including financial services and other areas of the economy. We've got to achieve that equilibrium appropriate."

The Treasury chief also confirmed she was cooperating with international partners "on our own essential resources approach, so that we are reduced dependence."

NHS Medicine Costs and Investment

Reeves also admitted that the price the National Health Service pays for medicines could rise as a consequence of ongoing discussions with the US government and its pharmaceutical firms, in exchange for lower tariffs and capital.

Some of the world's largest drug companies have said lately that they are either halting or canceling operations in the UK, with some attributing the modest returns they are obtaining.

Last month, the Science Minister said the cost the NHS spends on medicines would have to rise to prevent firms and pharmaceutical investment departing from the UK.

Reeves informed the BBC: "It has been observed as a result of the payment system, that medical research, innovative medicines have not been offered in the UK in the extent that they are in other EU nations."

"The objective is to ensure that individuals receiving treatment from the National Health Service are able to receive the top essential medicines in the globe. And so we are looking at these issues, and... aiming to obtain additional funding into the UK."